Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ABVC, Ardelyx, Ascletis, Beigene, PTC, Skye.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apollomics, Ascletis, Canbridge, Depymed, Neurosense.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amarin, Biomind Everest, Immunogen, Junshi, Kineta, Neurosense, Zielbio, Zynerba.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aeye Health, Roche, Rockfield Medical Devices, Tyber Medical.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Asieris, Beigene, Biomebank, Biontech, Brexogen, GSK, J Ints, Moderna, Novavax, Pfizer, Sanofi, Sinovac, Swedish Orphan Biovitrum, Takeda, YS.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, Alvotech, Ascendis, Astrazeneca, Avstera, Eagle, Ensysce, Gmax, Immune Bio, Merck & Co., Nuance, Oncopeptides, Protalix, UCB.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Perkinelmer, Xironetic.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biogx, Novocure, Trireme Medical.